| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MNMD (MNMD) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. MNMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | $10.23M | - | |
| CFO | 500.0K | - | - | |
| Other | 425.0K | $5.59M | - | |
| Other | 282.6K | $3.71M | - | |
| Dir | 75.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Barrow Robert | Chief Executive Officer | Sell | 8,273 | $3.51 | $29,038.23 | -3.3% | |
| Dec 21, 2022 | Barrow Robert | Chief Executive Officer | Sell | 3,861 | $2.69 | $10,386.09 | -1.5% | |
| Dec 21, 2022 | Karlin Dan | Chief Medical Officer | Sell | 1,211 | $2.69 | $3,257.59 | -0.5% | |
| Oct 27, 2022 | Karlin Dan | Chief Medical Officer | Sell | 1,185 | $2.91 | $3,452.21 | -0.2% | |
| Oct 25, 2022 | Barrow Robert | Chief Executive Officer | Sell | 1,207 | $2.81 | $3,391.67 | -0.5% | |
| Oct 18, 2022 | Barrow Robert | Chief Executive Officer | Sell | 1,220 | $3.11 | $3,794.20 | -0.5% | |
| Sep 27, 2022 | Karlin Dan | Chief Medical Officer | Sell | 1,205 | $5.70 | $6,869.95 | -0.2% | |
| Sep 26, 2022 | Barrow Robert | Chief Executive Officer | Sell | 1,264 | $5.51 | $6,964.64 | -0.5% | |
| Sep 16, 2022 | Barrow Robert | Chief Executive Officer | Sell | 1,350 | $7.26 | $9,801.00 | -0.5% | |
| Aug 31, 2022 | Karlin Dan | Chief Medical Officer | Sell | 1,204 | $11.67 | $14,050.68 | -0.4% |